pilocarpine has been researched along with Branch Vein Occlusion in 2 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Excerpt | Relevance | Reference |
---|---|---|
"Fifty-two per cent of central retinal vein occlusion and 71% of branch retinal vein occlusion eyes that released pigment showed a rise in intraocular pressure." | 1.28 | Mechanisms leading to an acute rise in intraocular pressure in retinal vein occlusion. ( Ansons, AM; Bryce, I; Clearkin, L, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halikiopoulos, D | 1 |
Serle, JB | 1 |
Ansons, AM | 1 |
Clearkin, L | 1 |
Bryce, I | 1 |
2 other studies available for pilocarpine and Branch Vein Occlusion
Article | Year |
---|---|
Angle closure glaucoma secondary to hemiretinal vein occlusion.
Topics: Glaucoma, Angle-Closure; Humans; Laser Therapy; Male; Middle Aged; Mydriatics; Pilocarpine; Pupil Di | 2001 |
Mechanisms leading to an acute rise in intraocular pressure in retinal vein occlusion.
Topics: Adult; Aged; Anterior Eye Segment; Diabetes Complications; Diabetes Mellitus; Eye; Female; Glucose T | 1990 |